Todays Pick
Editor’s Pick
-
Date:
Non-insulin Therapies for Diabetes Market to Reach USD 58.6 Billion by 2034, Driven by Rising Type 2 Diabetes Prevalence and Expanding Therapeutic Innovations
The global non-insulin therapies for diabetes market is poised for substantial growth over…
Trending Now
-
Date:
Non-insulin Therapies for Diabetes Market to Reach USD 58.6 Billion by 2034, Driven by Rising Type 2 Diabetes Prevalence and Expanding Therapeutic Innovations
The global non-insulin therapies for diabetes market is poised for substantial growth over…
-
Date:
Non-muscle Invasive Bladder Cancer Market to Reach USD 21.1 Billion by 2034, Expanding at a CAGR of 21.4% During Forecast Period
The global Non-muscle Invasive Bladder Cancer (NMIBC) Market was valued at US$ 2.6…
Latest Posts
-
Date:
Non-insulin Therapies for Diabetes Market to Reach USD 58.6 Billion by 2034, Driven by Rising Type 2 Diabetes Prevalence and Expanding Therapeutic Innovations
The global non-insulin therapies for diabetes market is poised for substantial growth over the next decade as healthcare systems worldwide…
-
Date:
Non-muscle Invasive Bladder Cancer Market to Reach USD 21.1 Billion by 2034, Expanding at a CAGR of 21.4% During Forecast Period
The global Non-muscle Invasive Bladder Cancer (NMIBC) Market was valued at US$ 2.6 Billion in 2023 and is projected to…
-
Date:
Trump Keeps Immunity from I.R.S. Audits, Even as $1.8 Billion Fund Falls Away
Even as they rebelled against a $1.8 billion fund for President Trump’s allies, Republicans looked the other way as his…
-
Date:
James Handy, Actor in ‘Top Gun: Maverick,’ Is Found Stabbed to Death
The 81-year-old actor had parts in films including “Top Gun: Maverick” and “Arachnophobia.” The son of his girlfriend was arrested…
-
Date:
Deal to Renew FISA Surveillance Law Falters in the Senate Over Pulte
Democrats who had been expected to supply the votes necessary to advance it balked after President Trump named Bill Pulte…
-
Date:
Nocturia Market to Reach USD 8.5 Billion by 2034, Led by Key Players Such as Ferring Pharmaceuticals, Astellas Pharma, and Pfizer
The global Nocturia market was valued at USD 3.7 billion in 2023 and is projected to reach USD 8.5 billion…